BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6336312)

  • 1. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
    Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
    Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.
    de Klein A; van Kessel AG; Grosveld G; Bartram CR; Hagemeijer A; Bootsma D; Spurr NK; Heisterkamp N; Groffen J; Stephenson JR
    Nature; 1982 Dec; 300(5894):765-7. PubMed ID: 6960256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.
    Bartram CR; de Klein A; Hagemeijer A; van Agthoven T; Geurts van Kessel A; Bootsma D; Grosveld G; Ferguson-Smith MA; Davies T; Stone M
    Nature; 1983 Nov 17-23; 306(5940):277-80. PubMed ID: 6580527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-abl and bcr are rearranged in a Ph1-negative CML patient.
    Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
    EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.
    Oshimura M; Ohyashiki K; Terada H; Takaku F; Tonomura A
    Cancer Genet Cytogenet; 1982 Mar; 5(3):187-201. PubMed ID: 6950809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
    Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
    Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of chromosomal region 9q34 in a case of variant Ph1 translocation t(22;22).
    Mareni C; Sessarego M; Coviello DA; Origone P; Ajmar F
    Leuk Res; 1986; 10(9):1131-7. PubMed ID: 3531733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
    Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
    N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
    Gale RP; Canaani E
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible evidence for acquired genetic activity at both chromosomal breakpoints of the Philadelphia translocation in chronic myeloid leukemia.
    Yamada T; Secker-Walker LM
    Leukemia; 1990 May; 4(5):341-4. PubMed ID: 2388479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia.
    Groffen J; Heisterkamp N; Stephenson JR; van Kessel AG; de Klein A; Grosveld G; Bootsma D
    J Exp Med; 1983 Jul; 158(1):9-15. PubMed ID: 6306134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?
    Hagemeijer A; Bartram CR; Smit EM; van Agthoven AJ; Bootsma D
    Cancer Genet Cytogenet; 1984 Sep; 13(1):1-16. PubMed ID: 6467178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.
    Romero P; Blick M; Talpaz M; Murphy E; Hester J; Gutterman J
    Blood; 1986 Mar; 67(3):839-41. PubMed ID: 3456250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomes and causation of human cancer and leukemia. XVI. Banding studies of chronic myelocytic leukemia, including five unusual Ph11 translocations.
    Hayata I; Sakurai M; Kakati S; Sandberg AA
    Cancer; 1975 Oct; 36(4):1177-91. PubMed ID: 1058043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Masked" Ph1-chromosome in chronic myelogenous leukaemia (CML).
    Verma RS; Dosik H
    Blut; 1985 Mar; 50(3):129-33. PubMed ID: 3856457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Philadelphia (Ph) chromosome in leukemia. I. A new mechanism due to interstitial deletion and insertion in chronic myelocytic leukemia.
    Hecht F; Morgan R; Schrier SL; Adams J; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):3-10. PubMed ID: 2981154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukemia and genetic events at 9q34.
    Lewis JP; Watson-Williams EJ; Lazerson J; Jenks HM
    Hematol Oncol; 1983; 1(3):269-74. PubMed ID: 6376316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Masked" philadelphia chromosome (Ph1) due to an unusual translocation.
    Marinello MJ; Morita M; Sandberg AA
    Cancer Genet Cytogenet; 1981 Apr; 3(3):227-32. PubMed ID: 6945148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.